Kamada is a growing commercial-stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions. The company is a leader in the specialty plasma-derived field focused on diseases with limited treatment alternatives, with 6 FDA-approved products selling in over 30 countries. The company is advancing an innovative development pipeline targeting areas of significant unmet medical need.
Looking for a particular KAMADA employee's phone or email?
The KAMADA annual revenue was $154.6 million in 2026.
Amir London is the CEO of KAMADA.
200 people are employed at KAMADA.
KAMADA is based in Rehovot, Central District.
The NAICS codes for KAMADA are [62151, 325, 32, 32541, 6215, 62, 3254, 621].
The SIC codes for KAMADA are [28, 283].